Dental
Women Care INC
Women Care INC was paid $20.48M by Medicaid between Jan 2018 and Dec 2024, across 102 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 82% of everything it billed.
33Billing provider infoWOMEN CARE INC
SCOTT DEPOT, WV 25560
SCOTT DEPOT, WV 25560
33aNPI1194759290assigned 07/11/2006
33bProvider typeDentist
28Total paid$20.48M
24GClaims298,176
24DCodes billed102
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Dentist providers in West Virginia
Rank by total paid#2 of 112
Median peer was paid$60K
This provider vs. median343×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RAY, JULIE controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 81,435 | $5.29M | |
| 2019 | 20,066 | $1.31M | |
| 2020 | 44,414 | $2.34M | |
| 2021 | 36,517 | $2.06M | |
| 2022 | 56,515 | $4.25M | |
| 2023 | 38,331 | $3.43M | |
| 2024incomplete | 20,898 | $1.81M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 82% | 125,888 | 86,317 | $16.69M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.1% | 58,042 | 42,528 | $1.25M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.7% | 21,024 | 16,743 | $344K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 5,629 | 4,792 | $155K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | <1% | 11,782 | 7,298 | $152K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,958 | 4,972 | $124K |
| 90686 | <1% | 3,274 | 2,898 | $115K | |
| 96127 | <1% | 10,860 | 9,022 | $110K | |
| S0281 | Medical home program, comprehensive care coordination and planning, maintenance of plan | <1% | 2,294 | 2,017 | $101K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,583 | 1,407 | $95K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 2,188 | 1,946 | $81K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,411 | 2,834 | $79K |
90 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,238 | $78K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,782 | $73K |
| 81002 | <1% | 2,050 | $71K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,840 | $61K |
| 3008F | <1% | 2,966 | $53K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,482 | $52K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 1,955 | $45K |
| 81025 | <1% | 2,171 | $44K | |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 53 | $40K |
| 90715 | <1% | 907 | $38K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 699 | $36K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,144 | $35K |
| 90649 | <1% | 767 | $34K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 1,221 | $33K |
| 90734 | <1% | 797 | $32K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 974 | $31K |
| 1090F | <1% | 653 | $29K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,036 | $28K |
| 90837 | Psychotherapy session, about an hour | <1% | 3,979 | $28K |
| 90633 | <1% | 633 | $27K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 970 | $26K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,636 | $25K |
| 90670 | <1% | 851 | $25K | |
| 99406 | <1% | 2,091 | $21K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 756 | $17K |
| 90648 | <1% | 472 | $16K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 246 | $15K |
| 90710 | <1% | 311 | $14K | |
| 82948 | <1% | 243 | $14K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 280 | $14K |
| 90723 | <1% | 273 | $11K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 361 | $9K |
| 90632 | <1% | 184 | $9K | |
| 90685 | <1% | 122 | $9K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 502 | $7K |
| 90473 | <1% | 255 | $7K | |
| 99385 | <1% | 65 | $4K | |
| 87210 | <1% | 99 | $4K | |
| 90680 | <1% | 118 | $4K | |
| 76830 | Ultrasound, transvaginal | <1% | 51 | $4K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 40 | $4K |
| 90681 | <1% | 91 | $4K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 63 | $4K |
| 3044F | <1% | 93 | $3K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 109 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 69 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 69 | $3K |
| 99383 | <1% | 57 | $3K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 51 | $3K |
| 90698 | <1% | 60 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 47 | $2K |
| D0220 | Intraoral - periapical first radiographic image | <1% | 251 | $2K |
| D0330 | Panoramic radiographic image | <1% | 103 | $2K |
| 90636 | <1% | 13 | $2K | |
| T1016 | Case management, each 15 minutes | <1% | 112 | $2K |
| 99381 | <1% | 42 | $2K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 24 | $2K |
| 90700 | <1% | 32 | $1K | |
| 85018 | <1% | 14 | $1K | |
| D0140 | Limited oral evaluation - problem focused | <1% | 111 | $892.86 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 12 | $741.94 |
| 99384 | <1% | 30 | $727.40 | |
| 92551 | <1% | 22 | $727.40 | |
| 90732 | <1% | 15 | $726.00 | |
| 3045F | <1% | 15 | $717.70 | |
| 0031A | <1% | 30 | $640.00 | |
| 99173 | <1% | 17 | $581.92 | |
| 59025 | Fetal non-stress test | <1% | 18 | $281.58 |
| 0072A | <1% | 33 | $280.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 91 | $211.89 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,090 | $137.58 |
| D1110 | Prophylaxis - adult | <1% | 118 | $102.00 |
| 0071A | <1% | 54 | $88.00 | |
| 90656 | <1% | 76 | $20.12 | |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | 0% | 50 | $0.00 |
| 3078F | 0% | 103 | $0.00 | |
| 11981 | 0% | 14 | $0.00 | |
| D0274 | Bitewings - four radiographic images | 0% | 29 | $0.00 |
| 90621 | 0% | 12 | $0.00 | |
| 90651 | 0% | 15 | $0.00 | |
| 90688 | 0% | 71 | $0.00 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 0% | 137 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 106 | $0.00 |
| 3074F | 0% | 146 | $0.00 | |
| 1036F | 0% | 105 | $0.00 | |
| 3079F | 0% | 64 | $0.00 | |
| 3075F | 0% | 13 | $0.00 | |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 0% | 34 | $0.00 |
| D0150 | Comprehensive oral evaluation - new or established patient | 0% | 14 | $0.00 |
| 99205 | Prolong outpt/office vis | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRAY, JULIE (CREDENTIALING SPECIALIST)
| Provider | Location | Paid |
|---|---|---|
| Womencare INC | Saint Albans, WV | $10.73M |
| Womencare, INC | Charleston, WV | $10.59M |
| Womencare INC | Charleston, WV | $7.42M |
| Womencare, INC | Madison, WV | $5.93M |
| Womencare INC | Barboursville, WV | $2.34M |
| Womencare INC | Charleston, WV | $1.85M |
| Womencare INC | Cross Lanes, WV | $1.64M |
| Womencare INC | Hurricane, WV | $1.02M |
| Womencare INC | Hurricane, WV | $838K |
| Womencare INC | Charleston, WV | $685K |
| Womencare, INC | Charleston, WV | $526K |
| Womencare INC | Dunbar, WV | $384K |
| Womencare INC | Marmet, WV | $348K |
| Womencare INC | Charleston, WV | $199K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.